OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
From bench to bedside: current development and emerging trend of KRAS-targeted therapy
Yi Chen, Qiu-pei Liu, Hua Xie, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 686-703
Closed Access | Times Cited: 11
Yi Chen, Qiu-pei Liu, Hua Xie, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 4, pp. 686-703
Closed Access | Times Cited: 11
Showing 11 citing articles:
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Structural Insights into Small-Molecule KRAS Inhibitors for Targeting KRAS Mutant Cancers
Divya Pandey, Subhash C. Chauhan, Vivek K. Kashyap, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116771-116771
Closed Access | Times Cited: 5
Divya Pandey, Subhash C. Chauhan, Vivek K. Kashyap, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116771-116771
Closed Access | Times Cited: 5
Resistance to KRAS inhibition in advanced non-small cell lung cancer
Katherina Bernadette Sreter, Maria Joana Catarata, Maximilian von Laffert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Katherina Bernadette Sreter, Maria Joana Catarata, Maximilian von Laffert, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Breaking barriers: the latest insights into KRAS G12C inhibitors
Fouad Attieh, Hampig Raphaël Kourié
Future Oncology (2024), pp. 1-4
Closed Access | Times Cited: 2
Fouad Attieh, Hampig Raphaël Kourié
Future Oncology (2024), pp. 1-4
Closed Access | Times Cited: 2
TIME Is Critical for Oncolytic Viral Therapies Against Solid Cancers
Vijay Kumar, John H. Stewart
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Vijay Kumar, John H. Stewart
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies
Luigi Liguori, Fabio Salomone, Angela Viggiano, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104554-104554
Open Access | Times Cited: 1
Luigi Liguori, Fabio Salomone, Angela Viggiano, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104554-104554
Open Access | Times Cited: 1
A new era with advanced immunotherapy
Claudia Badia Lopez, Elisabeth J. Ruijgrok, Casper H.J. van Eijck
Translational Gastroenterology and Hepatology (2024) Vol. 9, pp. 60-60
Open Access
Claudia Badia Lopez, Elisabeth J. Ruijgrok, Casper H.J. van Eijck
Translational Gastroenterology and Hepatology (2024) Vol. 9, pp. 60-60
Open Access
Novel potent SOS1 inhibitors containing a tricyclic quinazoline scaffold: a joint view of experiments and simulations
Luolong Qing, Zhengzai Cheng, Juan Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117065-117065
Closed Access
Luolong Qing, Zhengzai Cheng, Juan Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117065-117065
Closed Access
Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Discovery of novel tetracyclic quinazolines as multi-KRAS inhibitors for the treatment of solid tumors
Chang‐Hee Hong, Jooyun Lee, Dowon Kim, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130087-130087
Closed Access
Chang‐Hee Hong, Jooyun Lee, Dowon Kim, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130087-130087
Closed Access
